missing translation for 'onlineSavingsMsg'
Learn More

Fezolinetant, MedChemExpress

Code produit. 16413787
Encompass_Preferred
Click to view available options
Quantité:
1 mg
5 mg
10 mg
25 mg
50 mg
100 mg
Les retours ne sont pas autorisés pour ce produit. Afficher la politique du retour.

Code produit. 16413787

Marque: Medchem Express HY19632

Veuillez vous pour pouvoir commander cet article. Besoin d'un compte web? Créer le vôtre dès maintenant!

Dieser Artikel kann nicht zurückgegeben werden. Rückgaberichtlinie anzeigen

MedChemExpress Fezolinetant is an antagonist of the neurokinin 3 receptor (NK3R), used for the treatment of menopausal hot flushes.

Fezolinetant is an antagonist of the neurokinin 3 receptor (NK3R), used for the treatment of menopausal hot flushes.

Spezifikation

Nom chimique ou matériau Fezolinetant
CAS 1629229-37-3
Couleur Light Yellow
Notes de qualité de la pureté Research
Formule moléculaire C16H15FN6OS
Quantité 50 mg
Synonyme ESN-364
Informations sur la solubilité DMSO : 20 mg/mL (55.81 mM; Need ultrasonic)
SMILES O=C(N1[C@H](C)C2=NN=C(C3=NC(C)=NS3)N2CC1)C4=CC=C(F)C=C4
Poids moléculaire (g/mol) 358.39
Poids de la formule 358.39
Pourcentage de pureté 98.01%
Qualité Research
Forme physique Solid
Mehr anzeigen Weniger anzeigen

Research purposes only

Product Content Correction

The Fisher Scientific Encompass Program offers items which are not part of our distribution portfolio. These products typically do not have pictures or detailed descriptions. However, we are committed to improving your shopping experience. Please use the form below to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Thank You! Your feedback has been submitted. Fisher Scientific is always working to improve our content for you. We appreciate your feedback.